Gratwohl, AloisAloisGratwohlBaldomero, HelenHelenBaldomeroSchwendener, AlvinAlvinSchwendenerGratwοhl, ΜichaelΜichaelGratwοhlUrbano-Ispizua, AlvaroAlvaroUrbano-IspizuaFrauendorfer, KarlKarlFrauendorfer2023-04-132023-04-132007-03-01https://www.alexandria.unisg.ch/handle/20.500.14171/8094310.1038/sj.leu.2404509The tradeoff between ongoing expensive drug therapies in general or once in a lifetime procedure becomes relevant. Transplant rates for chronic myeloid leukemia across Europe provide an example. Economics matter as well as evidence.enEconomicsevidenceCMLtransplantation ratesjournal article